INR Calculator
Calculate INR from patient PT, control PT, and ISI to standardize clotting results across labs. Educational only, not treatment advice.
Enter the Details
Result will appear here...
Why a clotting time needs standardising
The prothrombin time, or PT, measures how many seconds a blood sample takes to clot through one particular pathway. It is the test used to monitor warfarin. But it has a problem that nearly sank it as a monitoring tool: the result depends heavily on the chemical reagent the lab uses to run it. Two labs testing the same blood with different reagents could report noticeably different PTs, which once led to genuinely dangerous differences in warfarin dosing from one place to another.
The International Normalized Ratio, the INR, is the fix. It is not a new test; it is a way of expressing the PT so that the number means the same thing everywhere, regardless of which reagent or machine produced it. That single idea, taking a lab-dependent second-count and turning it into a universal figure, is what the INR is for, and it is worth understanding before the arithmetic makes sense.
The ISI, and why it is the whole point
The piece that does the standardising is the ISI, the International Sensitivity Index. Every batch of the clotting reagent (the thromboplastin) is assigned an ISI by its manufacturer, measured against an international reference material held by the World Health Organization. The ISI captures how responsive that particular reagent is. A highly responsive modern reagent sits close to 1.0, which is why this calculator defaults the ISI there and treats anything far from it as suspect.
Here is the elegant part. The INR does not just divide the patient's PT by a normal PT; it raises that ratio to the power of the ISI. Exponentiating by the ISI is exactly what cancels out the reagent's own sensitivity, so a sluggish reagent and a brisk one, fed the same blood, land on the same INR. When the ISI happens to be 1.0, the exponent does nothing and the INR is simply the PT ratio. The further the reagent's ISI is from 1.0, the more work that exponent is doing to bring the result back into line.
Working through the numbers
Putting that together, the formula is:
INR = (patient PT ÷ control PT)ISI
where the control PT is the laboratory's mean normal PT, and the ISI is the reagent's index. Take a patient PT of 22 seconds, a control PT of 12 seconds, and an ISI of 1.2:
INR = (22 ÷ 12)1.2
INR = 1.831.2
INR ≈ 2.07
So this patient's PT, which on its own looks like an unremarkable "22 seconds", expresses as an INR of about 2.07, squarely in the usual treatment range. Note what the ISI did: had you skipped it and just taken the ratio, you would have reported 1.83, meaningfully lower. That gap is the whole reason the index exists.
What INR are you aiming for?
In someone not taking an anticoagulant, the INR sits around 1.0. On warfarin, the target is not a single value but a range that depends on why the person is being treated:
| Indication | Usual target INR |
|---|---|
| Atrial fibrillation, DVT or PE treatment, most tissue heart valves | 2.0 to 3.0 |
| Most mechanical heart valves, antiphospholipid syndrome | 2.5 to 3.5 |
The logic is a balancing act. Warfarin thins the blood, so too low an INR leaves the person under-treated and at risk of the clot you were trying to prevent, while too high an INR tips toward bleeding. The target range is the sweet spot for a given condition, and dosing is nudged up or down to stay inside it. A very high INR, well above the target, is a recognised warning sign in its own right.
What this tool can and cannot tell you
This matters more here than on most calculators, so plainly: this is a computational aid, not a lab result and not medical advice. Do not start, stop or adjust warfarin based on a number from this page. A few specific limits:
- The INR system is validated for stable warfarin-type (vitamin K antagonist) therapy. It does not apply to the direct oral anticoagulants, and it is not a general measure of clotting in acute bleeding.
- Point-of-care finger-prick devices can read differently from a formal laboratory INR.
- Many things shift a real INR that this arithmetic knows nothing about: illness, liver problems, antibiotics and other drug interactions, and changes in dietary vitamin K.
- The result is only as good as the inputs, and the correct control PT and ISI come from the testing laboratory, not from a guess.
Used for what it is, seeing how PT, control and ISI combine into a standardised figure, it is genuinely useful. Any actual anticoagulation decision belongs with the clinician managing it.
Questions people ask
Where do I find the ISI?
It comes from the laboratory: it is a property of the specific thromboplastin reagent and instrument they use, printed by the manufacturer. Modern reagents are usually close to 1.0. If you do not have the real value, the calculation cannot be accurate, since the ISI is the part that standardises the result.
What does a high INR mean?
Relative to a target, a high INR means the blood is taking longer to clot than intended, which shifts the balance toward bleeding risk. How high is too high depends on the person's target range and situation, and a markedly raised INR is something to act on clinically rather than interpret from a calculator.
Is an INR of 1 normal?
For someone not on anticoagulants, yes: a healthy INR sits around 1.0, roughly 0.8 to 1.2. On warfarin, though, an INR of 1.0 would usually be too low, because the whole point of treatment is to raise it into the target range for their condition.
References
Where the figures come from. The INR formula and the standardising role of the ISI against a WHO reference thromboplastin are set out in the StatPearls clinical reference, which also gives the target INR ranges by indication used above.
- International Normalized Ratio: Assessment, Monitoring, and Clinical Implications. In: StatPearls. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK507707/
- Current Concepts in Anticoagulant Therapy. Mayo Clinic Proceedings. Therapeutic INR ranges for oral anticoagulant treatment (2.0 to 3.0 for most conditions; 2.5 to 3.5 for mechanical cardiac valves).
Dr. Ashish Lamichhane is an MBBS doctor currently serving as an ASBA medical officer and hospital chief, with a background in general medicine and clinical practice. His work brings real world medical perspective to health related calculation tools and everyday decision support utilities. At Eon Tools, he reviews health tools.